Biofrontera (BFRI) Other Non-Current Assets (2020 - 2025)

Biofrontera's (BFRI) quarterly Other Non-Current Assets came in at $360000.0 in Q4 2025, down 6.01% year-on-year from $383000.0 in Q4 2024, and down 23.73% quarter-over-quarter from $472000.0 in Q3 2025.

Biofrontera (BFRI) Other Non-Current Assets (2020 - 2025) Analysis & Trends

Biofrontera's Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $360000.0 for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets fell 6.01% year-over-year to $360000.0 in Q4 2025; TTM through Dec 2025 was $360000.0, a 6.01% decrease from a year earlier, with the FY2025 full-year figure at $360000.0, down 6.01% from the prior year.
  • Other Non-Current Assets slipped to $360000.0 in Q4 2025 per BFRI's latest filing, from $472000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $1.4 million in Q3 2021 and bottomed at $85000.0 in Q3 2022.
  • The 5-year median for Other Non-Current Assets is $383000.0 (2024), against an average of $400176.5.
  • Across the five-year window, Other Non-Current Assets tumbled 93.81% in 2022 and jumped 478.82% in 2023, its largest moves.
  • Year by year, Other Non-Current Assets stood at $268000.0 in 2021, then slumped by 68.28% to $85000.0 in 2022, then soared by 467.06% to $482000.0 in 2023, then fell by 20.54% to $383000.0 in 2024, then fell by 6.01% to $360000.0 in 2025.
  • Per Business Quant, the three latest BFRI Other Non-Current Assets figures stand at $360000.0 (Q4 2025), $472000.0 (Q3 2025), and $535000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Biofrontera 12.70 Mn 6.29 Mn 14.09 Mn 360,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 360,000.00
Sep 30, 2025 472,000.00
Jun 30, 2025 535,000.00
Mar 31, 2025 453,000.00
Dec 31, 2024 383,000.00
Sep 30, 2024 383,000.00
Jun 30, 2024 324,000.00
Mar 31, 2024 328,000.00
Dec 31, 2023 482,000.00
Sep 30, 2023 492,000.00
Mar 31, 2023 384,000.00
Dec 31, 2022 85,000.00
Sep 30, 2022 85,000.00
Jun 30, 2022 128,000.00
Mar 31, 2022 268,000.00
Dec 31, 2021 268,000.00
Sep 30, 2021 1.37 Mn
Dec 31, 2020 121,000.00